Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
Martin C. Tammemägi(Brock University), Christine D. Berg(Prevention Group), Timothy R. Church(University of Minnesota), Gerard A. Silvestri(MUSC Hollings Cancer Center), William G. Hocking(Marshfield Clinic), Paul A. Kvale(Henry Ford Health System), Thomas L. Riley(Automation, Information, and Management Systems (United States)), John Commins(National Institutes of Health)
Cited by 361
Related Papers
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
|New England Journal of Medicine|1993|3.3k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Methods for Staging Non-small Cell Lung Cancer
|CHEST Journal|2013|1.5k
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
|New England Journal of Medicine|2013|1.4k
The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer
|New England Journal of Medicine|2000|1.4k